Session » Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Date: Sunday, October 21, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 728

A Higher Activity Index at Initial Renal Biopsy Is Associated with Rapid Progression to Renal Failure in Patients with Refractory Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 714

A Predictive Clinical-Immunological Index for Infections Unveils Novel Innate and Adaptive Immunity Abnormalities As Key Risk Factors for Infections in a Cohort of Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 730

Accrual of Atherosclerotic Vascular Events over 10 Years in a Multicentre Inception SLE Cohort

9:00AM-11:00AM: Abstract Number: 733

Advanced Chronic Kidney Disease in Lupus Nephritis: Factors Leading to Progression

9:00AM-11:00AM: Abstract Number: 710

An Analysis of Cell-of-Origin in Diffuse Large B-Cell Lymphoma in Systemic Lupus Erythematosus, Including Molecular and Clinical Factors Associated with Survival

9:00AM-11:00AM: Abstract Number: 726

Anti-Retinoblastoma Protein Antibody Is Protective Against Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 762

Aquaporin-4 Immunoglobulin G Antibody Positive Neuromyelitis Optica Spectrum Disorder and Systemic Autoimmune Diseases Overlap Syndrome: A Single Center Experience

9:00AM-11:00AM: Abstract Number: 724

Are Traditional Biomarkers of Lupus Associated with Renal Pathology in Lupus Nephritis?

9:00AM-11:00AM: Abstract Number: 718

Assessing Dyspnea in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 744

Association of PCSK9 Serum Levels with Lipid Metabolism Dysregulation, Activity/Damage Scores and Subclinical Atherosclerosis in SLE Patients

9:00AM-11:00AM: Abstract Number: 737

Atherogenic Index of Plasma in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A 10-Year Potential Predictor of Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 729

Atherosclerotic Vascular Events in SLE – an Evolving Story

9:00AM-11:00AM: Abstract Number: 740

Can Monocyte Chemo-Attractant Protein-1differentiate Different Histological Classes in Lupus Nephritis?

9:00AM-11:00AM: Abstract Number: 764

Cardiovascular Disease in SLE at One Center between 1981 and 2016. a Population-Based Study Highlighting the Importance of Disease Duration and Age at Diagnosis

9:00AM-11:00AM: Abstract Number: 741

Cardiovascular Risk Re-Classification Using Carotid Ultrasound in Systemic Lupus Erythematosus Patients Is Related to the Damage Produced By the Disease

9:00AM-11:00AM: Abstract Number: 779

Cerebrospinal Fluid Biomarkers for Diagnosing Neuropsychiatric SLE: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 731

Clinical Characteristics and Neurophysiological Patterns of Peripheral Neuropathies in Patients with Systemic Lupus Erythematosus: A Single Center Experience

9:00AM-11:00AM: Abstract Number: 774

Clinical Variables and Serologic Markers of Disease Activity Do Not Aid in Early Recognition of Patients with Tubulointerstitial Disease Who Have No Significant Renal Impairment at Time of Biopsy

9:00AM-11:00AM: Abstract Number: 770

Cognitive Function Trajectories Are Associated with the Depressive Symptoms Trajectories in SLE over Time

9:00AM-11:00AM: Abstract Number: 782

Cognitive Impairment and Health-Related Quality of Life in a Lupus Cohort

9:00AM-11:00AM: Abstract Number: 763

Comparison of Clinical Characteristics and Outcome between Isolated and Classic Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 759

Comparison of Length of Stay and Total Hospital Charges for Hospitalizations for Sepsis in Patients with Systemic Lupus Erythematosus: A Study of National Inpatient Sample Database 2010 to 2014

9:00AM-11:00AM: Abstract Number: 751

Coronary Plaque Burden in Patients with Lupus Compared to Healthy Volunteers

9:00AM-11:00AM: Abstract Number: 785

Correlation between Nailfold Capillary Number and Blood Perfusion in Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 758

Cutaneous Lupus Erythematosus Patients with a Negative ANA Meeting Acr and/or SLICC Criteria for Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 772

Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality Rate in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid Analysis

9:00AM-11:00AM: Abstract Number: 754

Determinants of Major Neurocognitive Disorder (Vascular Dementia) in SLE: The Importance of Treatment Adherence of SLE Disease Activity and Cardiovascular Risk Factors

9:00AM-11:00AM: Abstract Number: 760

Diagnosing SLE Arthritis with Dynamic Diffuse Optical Spectroscopy

9:00AM-11:00AM: Abstract Number: 709

Differential Characteristics of Lupus Psychosis and Steroid Psychosis

9:00AM-11:00AM: Abstract Number: 771

Does Cognitive Function Change over-Time in Systemic Lupus Erythematosus?

9:00AM-11:00AM: Abstract Number: 777

Electrocardiographic Abnormalities Are Associated with the Occurrence of Strokes in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 755

Elevated Serum Procalcitonin at Baseline Correlates with Reduced Survival in Patients with Lupus Myocarditis

9:00AM-11:00AM: Abstract Number: 775

Endomyocardial Biopsies in the Diagnosis of Myocardial Involvement in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 773

Exploring the Relation between Immunoglobulins Level and Infection Risk in Adult Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 736

Herpes Zoster and Disseminated Zoster in Systemic Lupus Erythematosus and Lupus Nephritis: Incidence Rates in Real-World Claims Data

9:00AM-11:00AM: Abstract Number: 769

Herpes Zoster in Systemic Lupus Erythematosus: Prevalence and Risk Factors

9:00AM-11:00AM: Abstract Number: 712

Higher Prednisolone Dose during Treatment of Tuberculosis Correlates with Mortality during Tuberculosis Treatment in Systemic Lupus Erythematosus Patients: A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 732

Impact of Disease Course on Atherosclerotic Vascular Events, Osteoporosis and Osteonecrosis in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 746

Impact of Nephritis on the Outcomes of SLE Patients Hospitalized with Acute Myocardial Infarction; Insights from the National Inpatient Sample Database

9:00AM-11:00AM: Abstract Number: 722

Increased Blood Pressure Visit-to-Visit Variability in Patients with Systemic Lupus Erythematosus: Association with Inflammation, Comorbidities and Increased Mortality

9:00AM-11:00AM: Abstract Number: 706

Increased Incidence and Prevalance of Resistant Hypertension in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 727

Increased Risk of Coronary Artery Disease Among Patients with Class III Lupus Nephritis: A Retrospective Study of Patients at the University of North Carolina at Chapel Hill

9:00AM-11:00AM: Abstract Number: 720

Interkeukin-6 Level in Cerebrospinal Fluid As a Biomarker for Systemic Lupus Erythematosus Patients with Longitudinally Extensive Transverse Myelitis like Neuromyelitis Optica Spectrum Disease

9:00AM-11:00AM: Abstract Number: 749

Is Lupus Nephritis Onset Delayed in Older Caucasian Females with Less Aggressive Pathology?

9:00AM-11:00AM: Abstract Number: 748

Long-Term Survival of Renal Transplantation Due to Lupus Nephritis. Comparative Study with Non-Autoimmune Transplantation. Study from a Single Center

9:00AM-11:00AM: Abstract Number: 719

Men and Sexual Function: An Overlooked Issue in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 704

Metabolomics Analysis of Insulin Resistance in Mild/Inactive Non-Diabetic Systemic Lupus Erythematosus Women

9:00AM-11:00AM: Abstract Number: 776

MMP7 and CXCL12: Two Promising Biomarkers in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 742

Moderate to Severe Depression in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 766

Neutrophil Extracellular Traps Are a Source of Extracellular High Mobility Group Box-1: Association with Clinical and Histopathological Features in Patients with Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 743

Outcome of Stroke in Patients with Systemic Lupus Erythematosus: A Nested Case-Control Study

9:00AM-11:00AM: Abstract Number: 723

Patient-Reported Cognitive Screen Does Not Identify Cognitive Sub-Domains: Exploration of the Subscale Structure of the Perceived Deficits Questionnaire in a Systemic Lupus Erythematosus Cohort

9:00AM-11:00AM: Abstract Number: 756

Peripheral Neutrophil CD64 Index Combined with Biomarkers Improves the Ability of Diagnosing Bacterial Infection in Patients with SLE

9:00AM-11:00AM: Abstract Number: 750

Positive Remodeling Index and Low Attenuation Non-Calcified Coronary Plaques: Markers of Vulnerable Coronary Plaques in Systemic Lupus?

9:00AM-11:00AM: Abstract Number: 784

Prediction of Hospital-Acquired Bacterial Infections in Patients with SLE

9:00AM-11:00AM: Abstract Number: 765

Predictors of End-Stage Renal Disease in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 725

Preliminary Population-Based Incidence and Prevalence Estimates of Primary Discoid Lupus and Cutaneous Lupus Erythematosus from the Manhattan Lupus Surveillance Program

9:00AM-11:00AM: Abstract Number: 752

Prevalence and Predictors of Peripheral Vascular Disease in a Cohort of Systemic Lupus Erythematosus (SLE) Patients

9:00AM-11:00AM: Abstract Number: 705

Prevalence of Cervical Human Papillomavirus Infection in Women with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 783

Procalcitonin and CXCL9 As Potential Biomarkers for Pneumonia in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 745

Prolonged Remission and Influence on Damage Accrual and Infection for Patients with Systemic Lupus Erythematosus: A Multi-Center Cohort Study from China

9:00AM-11:00AM: Abstract Number: 761

Protein/Creatinin Urinary Index Has Concordance with 24 Hour Urinary Proteinuria in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 778

Rates of Herpes Zoster Virus Infection in SLE Patients on Immunosuppression

9:00AM-11:00AM: Abstract Number: 711

Recurrence of Lupus Nephritis in Renal Transplant Recipients

9:00AM-11:00AM: Abstract Number: 715

Septic Shock Among Patients with Systemic Lupus Erythematosus: Short and Long-Term Outcome and Cost. Analysis of the French Nationwide Database

9:00AM-11:00AM: Abstract Number: 735

Serum Albumin at One Year Predicts Long-Term Renal Outcome

9:00AM-11:00AM: Abstract Number: 781

Simultaneous Identification of Two Biomarkers in ACTIVE LUPUS Nephritis: Autophagy in Treg CELLS and Prolactin Receptors in B Lymphocytes

9:00AM-11:00AM: Abstract Number: 716

Soluble CD163 Is a Biomarker Associated with Accelerated Carotid Atheroma in SLE Patients at Otherwise Low Risk for Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 713

Soluble ST2 and CXCL-10 May Serve As Biomarkers of Diastolic Dysfunction in SLE and Correlate with Disease Activity and Damage

9:00AM-11:00AM: Abstract Number: 768

Spinal Cord Syndromes Associated with Systemic Lupus Erythematous: Differentiating Lupus Myelitis, Neuromyelitis Optica, and Multiple Sclerosis

9:00AM-11:00AM: Abstract Number: 707

Subclinical Parameters of Arterial Stiffness and Arteriosclerosis Correlate with QRISK3 in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 717

The Burden of Chronic Kidney Disease in Systemic Lupus Erythematosus (SLE): A Nationwide Epidemiologic Study

9:00AM-11:00AM: Abstract Number: 721

The Burden of Renal Arteriosclerosis in Lupus Nephritis: A Cohort Study Examining Prevalence and Predictors of Renal Arteriosclerosis

9:00AM-11:00AM: Abstract Number: 747

The Influence of Depression on Clinical Features of Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 708

The Montreal Cognitive Assessment Test. a Useful Tool in Screening of Cognitive Impairment in Patients with Systemic Lupus Erythematosusshort Title: Cognitive Impairment in SLE

9:00AM-11:00AM: Abstract Number: 734

The Role of Micro-RNA 142-3p Expression in Lupus Nephritis in an Egyptian Cohort

9:00AM-11:00AM: Abstract Number: 767

Tobacco and Systemic Lupus Erythematosus Relationships: Pay Attention to the Retina!

9:00AM-11:00AM: Abstract Number: 738

Two Clinical Phenotypes of Chinese SLE-PAH Patients

9:00AM-11:00AM: Abstract Number: 757

Urinary Galectin-3 Binding Protein As a Novel Biomarker of Renal Disease Activity in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 739

Urine and Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Differentially Correlates with Renal and Non-Renal Systemic Lupus Erythematosus (SLE): A Prospective, Case-Control Study

9:00AM-11:00AM: Abstract Number: 780

Urine Metabolomic Profile in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 753

Young SLE Patients Have Higher Coronary Artery Calcium Scores Compared with Population Controls

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].